Barinat 4 mg

Description

Barinat 4 mg Tablet contains baricitinib, an oral medicine that belongs to a class of medicines called Janus kinase (JAK) inhibitors. Baricitinib works by reducing the activity of certain enzymes involved in immune and inflammatory responses.

Barinat 4 mg may be prescribed for certain inflammatory and immune-related conditions, including moderate-to-severe rheumatoid arthritis, atopic dermatitis, and severe alopecia areata, depending on the patient’s condition, age, medical history, and applicable regulatory guidelines. Treatment should be determined and monitored by a qualified healthcare professional.

Key Information

• Active Ingredient: Baricitinib
• Strength: 4 mg
• Dosage Form: Tablet
• Therapeutic Category: Immunomodulator / JAK inhibitor
• Drug Class: Janus kinase (JAK) inhibitor
• Route of Administration: Oral

How Barinat 4 mg Works

Barinat 4 mg contains baricitinib, which selectively inhibits Janus kinase enzymes, particularly JAK1 and JAK2. These enzymes are involved in signaling pathways that regulate inflammation and immune activity. By reducing JAK signaling, baricitinib can help decrease excessive inflammatory activity associated with certain conditions.

Frequently Asked Questions

1. What is Barinat 4 mg used for?
Barinat 4 mg contains baricitinib and may be prescribed for certain immune-mediated conditions, including moderate-to-severe rheumatoid arthritis, atopic dermatitis, and severe alopecia areata, depending on applicable treatment guidelines and patient eligibility.

2. How does Barinat 4 mg work?
Barinat contains baricitinib, which inhibits JAK1 and JAK2 enzymes involved in immune and inflammatory signaling. This helps reduce excessive inflammation associated with certain diseases.

3. What are the possible side effects of Barinat 4 mg?
Possible side effects include upper respiratory tract infections, nausea, headache, herpes infections, and urinary tract infections. Baricitinib can also cause changes in blood counts and cholesterol levels. Seek medical attention for signs of a serious infection, blood clot, or severe allergic reaction.

4. Who should not take Barinat 4 mg?
Barinat may not be suitable for people with certain active or serious infections, significant liver or kidney problems, or particular cardiovascular, clotting, or cancer risk factors. Your healthcare professional should evaluate your medical history before treatment.

5. Do I need medical monitoring while taking Barinat 4 mg?
Yes. Because baricitinib affects the immune system and can influence blood counts, cholesterol, liver function, and infection risk, your healthcare professional may recommend laboratory tests and regular monitoring during treatment.